Skip to main content

ZEPOSIA 7-Day Starter Pack, ZEPOSIA, ZEPOSIA Starter Kit

Unverified·never
ICD-10 indication
G35

Affordability Check

How much will you actually pay for ZEPOSIA 7-Day Starter Pack, ZEPOSIA, ZEPOSIA Starter Kit?

In 30 seconds, see every legitimate way to afford ZEPOSIA 7-Day Starter Pack, ZEPOSIA, ZEPOSIA Starter Kit — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About ZEPOSIA 7-Day Starter Pack, ZEPOSIA, ZEPOSIA Starter Kit

What is this medication? ZEPOSIA is a prescription medication used to treat adults with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. It is also indicated for the treatment of adults with moderately to severely active ulcerative colitis. The drug works as a sphingosine 1-phosphate receptor modulator, which helps keep certain white blood cells in the lymph nodes to prevent them from reaching the central nervous system or the colon, thereby reducing inflammation and damage.

The ZEPOSIA 7-Day Starter Pack and ZEPOSIA Starter Kit are used to begin the treatment process through a gradual increase in dosage. Because starting the full dose immediately can cause a temporary decrease in heart rate, these kits provide a specific titration schedule over the first week. This allows the body to adjust to the medicine safely before the patient moves on to the standard daily maintenance dose for long-term management of their condition.

Copay & patient assistance

  • Patient Copay Amount: As little as $0 per month for the ZEPOSIA prescription; as little as $0 for out-of-pocket medical assessment costs (blood tests, ECG, and eye exam).
  • Maximum Annual Benefit Limit: Prescription benefit limits vary and are determined by Bristol Myers Squibb based on the patient's drug plan; medical assessment benefit is subject to a maximum benefit of $2,000.
  • Core Eligibility Restrictions: Must be 18 years of age or older and reside in the U.S. or Puerto Rico. Must have commercial (private) insurance. Not valid for patients with government-sponsored insurance (including Medicare, Medicaid, TRICARE, or VA). Medical assessment benefit is not available to residents of Massachusetts, Minnesota, or Rhode Island.
  • RxBIN, PCN, and Group numbers: Not Publicly Available.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.